Product

Introduction to Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP The Metformin Hydrochloride Prolonged Release and Glimepiride Tablets IP are a combination medication used to reduce high blood sugar levels in individuals diagnosed with type 2 diabetes. This tablet contains two active ingredients:

• Metformin Hydrochloride – a prolonged-release formulation that helps control blood glucose levels by reducing glucose production in the liver and increasing the body’s sensitivity to insulin.
• Glimepiride – a sulfonylurea that stimulates the release of insulin from the pancreas, further contributing to the management of type 2 diabetes.

This combination therapy is essential for effectively managing type 2 diabetes, especially when accompanied by a proper diet and regular exercise routine. It is crucial to follow the prescribed dosage and duration as advised by a healthcare professional to achieve optimal results and avoid potential side effects.

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. Duis autem vel eum iriure dolor in hendrerit in vulputate velit esse molestie consequat, vel illum dolore eu feugiat nulla facilisis at vero eros et accumsan et iusto odio dignissim qui blandit praesent luptatum zzril delenit augue duis dolore te feugait nulla facilisi.
Lorem ipsum dolor sit amet, cons ectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat.